← Back

DLH: DLH Holdings Corp. Posts Mixed FY2025 Results Amidst Transition and Contract Unbundling

DLH Holdings Corp. reported revenue of $81.2 million in the fourth quarter, down from $96.4 million in the prior year period, primarily due to small business set-aside conversions and contract unbundling, which accounted for approximately $11 million of the revenue contraction. EBITDA was $6.6 million, down from $10.7 million last year, mainly due to lower revenue and pressure on gross margins. The company's EPS was $0.02, in line with estimates. The reduction in debt by $10.7 million during the quarter brought the fiscal year-end debt balance to $131.6 million, a total reduction of $23 million over the 12-month period.

DLHC

USD 5.64

1.44%

A-Score: 3.8/10

Publication date: December 11, 2025

Full Report

Author: Analystock.ai

📋 Highlights
  • Revenue Decline Q4 revenue fell to $81.2M from $96.4M YoY, primarily due to $11M contraction from small business set-aside conversions and contract unbundling.
  • EBITDA Drop EBITDA decreased to $6.6M from $10.7M YoY, driven by lower revenue and margin pressures, though margins are expected to normalize post-2026.
  • Debt Reduction Achieved $10.7M debt reduction in Q4, totaling $23M over FY2025, with $131.6M remaining, and all mandatory term debt payments made a year ahead of schedule.
  • Cybersecurity Certification Earned CMMC Level 2 Certification, enhancing cybersecurity credentials to compete for higher-value contracts.
  • Pipeline Growth Qualified opportunity pipeline exceeds $3B for 24+ months, with strong defense and digital transformation prospects driving FY2026 optimism.

Operational Highlights and Outlook

The company achieved significant milestones, including national award recognition for developing innovative countermeasures for diseases and health risks, and elevating the readiness posture of the naval fleet. DLH Holdings Corp. is optimistic about growth opportunities in its addressable market, having expanded its role in leading industry organizations and research consortiums, and achieved Cybersecurity Maturity Model Level 2 Certification. The company was awarded an extension of its IDIQ contract by the VA to provide pharmaceutical and medical logistics services. As Zach Parker, President and CEO, noted, "We've ended the fiscal year in position for the opportunities of tomorrow... We're optimistic about the growth opportunities in our addressable market."

Valuation and Growth Prospects

With a current P/E Ratio of 59.54 and EV/EBITDA of 6.82, the market is pricing in a certain level of growth. Analysts estimate next year's revenue growth at -32.1%. However, the company is confident about its growth prospects, with a strong pipeline valued at over $3 billion for a 24-plus month period. The company's diversified customer base and capabilities, along with investments in innovation, are expected to drive growth. The anticipated debt reduction in fiscal 2026 is expected to align with historical performance, converting approximately 50% to 55% of EBITDA to debt reduction.

Key Metrics and Future Expectations

The company's fundamentals focus on growth, scale, and cash flow generation, with a target to return to historical gross and EBITDA margins. The current P/S Ratio is 0.24, and the Net Debt / EBITDA is 4.37. As Kathryn JohnBull, CFO, emphasized, "growth is critical to return to historical growth and EBITDA margins." The company is expected to provide additional color on its future prospects in FY '26 and beyond.

DLH's A-Score